Results 201 to 210 of about 2,117,746 (268)

A cohort study of the duration of immunity to yellow fever after 4 years of primary vaccination in children and adults. [PDF]

Trans R Soc Trop Med Hyg
Saucha CVV, de Oliveira RVC, Maia MLS, Sousa ESS, de Oliveira PMN, Xavier JR, de Castro TDM, Cruz RLS, Schwarcz WD, Pereira RC, Azevedo AS, de Filippis AMB, Ferroco CLV, Andrade MFS, Simões M, Neto JC, Martins-Filho OA, Campi-Azevedo AC, de Lima SMB, Camacho LAB.   +19 more
europepmc   +1 more source

Kinetics of foot-and-mouth disease antibody response in cattle vaccinated with FMD-HS-BQ combined vaccine under field condition. [PDF]

Front Microbiol
Ranjan R, Joshi HR, Pandey V, Biswal JK, Das S, Barik B, Mohapatra JK, Mallick S, Singh RP.   +8 more
europepmc   +1 more source

Autoimmune nodopathy associated with Sjögren's disease and nephrotic syndrome: a case report and literature review. [PDF]

Front Immunol
Zhang X, Niu D, Chen R, Yu H, Xing G.
europepmc   +1 more source

Evaluation of plasma anti-CS3 and anti-LTB IgG avidity among Zambian children vaccinated with ETVAX. [PDF]

PLoS One
Mubanga C, Mubanga M, Chilyabanyama ON, Phiri M, Chisenga CC, Glashoff RH, Chilengi R.   +6 more
europepmc   +1 more source

Modified Anti-PstS1 Bi-specific antibodies unlock potent protection against tuberculosis. [PDF]

PLoS Pathog
Akanksha, Bouzeyen R, Watson A, Wiseglass G, Sithole N, Abramovitz L, Ben-Shalom N, Rubinstein R, Javid B, Freund NT.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Computational Analysis of Antibody Paratopes for Antibody Sequences in Antibody Libraries

2022
To ensure the functionalities of the antibodies in phage-displayed synthetic antibody libraries, we use computational method to evaluate the designs of the antibody libraries. The computational methodologies developed in our lab for designing antibody library provide rich information on the function of the designed antibody sequences-adequate antibody ...
Hung-Pin, Peng, An-Suei, Yang
openaire   +2 more sources

Antibody and antibody fragments for cancer immunotherapy

Journal of Controlled Release, 2020
Antibody has become the most rapidly expanding class of pharmaceuticals for treating a wide variety of human diseases including cancers. Especially, with the fast development of cancer immunotherapy, antibody drugs have become the most promising therapeutic for curing cancers.
Weizhi Chen, Yang Yuan, Xiqun Jiang
openaire   +2 more sources